AI-based Clinical Trial Solutions For Patient Matching Market Size, Share & Trends Analysis Report By Therapeutic Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 4 Business Days
AI-based Clinical Trial Solutions For Patient Matching Market Growth & Trends
The global AI-based clinical trial solutions for patient matching market size is expected to reach USD 1.9 billion by 2030, registering a compound annual growth rate (CAGR) of 26.7% during the forecast period, according to a new report by Grand View Research, Inc. The major factors attributing the industry growth are the increasing worldwide incidences of chronic diseases, rising investment in the expansion of the healthcare sector, and the introduction of new technologies.
The rising adoption of artificial intelligence(AI)-based technologies for conducting clinical trials and the increasing number of start-ups in this field are also opening new opportunities for the market. For instance, in February 2022, in their seed funding, Qureight raised USD 1.50 million for their AI-based platform which reduces the timeline for the clinical trials process and further helps in reducing the cost of medicine development. Major bio-pharma giants are implementing advanced technological solutions for better patient management and clinical trial results.
These platforms further reduce clinical trial cycle time & cost, thereby increasing productivity & accuracy of the trial development. AI-based solutions incorporate natural language processing (NLP) algorithms which enhances the match rate between clinical trials and patient enrollment. For instance, AI-enabled clinical trial solutions used in matching patients have increased patient recruitment in lung cancer trial studies by 58.4%. Such advantages are further driving the market growth.
Based on therapeutic application, oncology held the largest market share 23.2% in 2021 owing to the rise in the prevalence of cancer all over the globe and rising initiatives to develop therapeutic solutions for oncology. However, the cardiovascular disease segment is expected to show the fastest growth rate during the forecast period owing to increasing cases of heart attack, stroke, and others.
Based on end users, pharmaceutical companies accounted for the highest revenue share of 66.0% owing to the growing focus on better development of bio-markers and diagnostics using AI-based technologies to identify the new medicine target and simplify the process of development of medicine and clinical trials by key players of pharmaceutical companies.
Based on the region North America held the largest market share of 43.8% in 2021. However, Asia Pacific is expected to show the fastest growth rate during the forecast period due to the increasing penetration of AI-based clinical technologies and supportive government initiatives for adopting AI.
AI-based Clinical Trial Solutions For Patient Matching Market Report Highlights
AI-based Clinical Trial Solutions For Patient Matching Market Growth & Trends
The global AI-based clinical trial solutions for patient matching market size is expected to reach USD 1.9 billion by 2030, registering a compound annual growth rate (CAGR) of 26.7% during the forecast period, according to a new report by Grand View Research, Inc. The major factors attributing the industry growth are the increasing worldwide incidences of chronic diseases, rising investment in the expansion of the healthcare sector, and the introduction of new technologies.
The rising adoption of artificial intelligence(AI)-based technologies for conducting clinical trials and the increasing number of start-ups in this field are also opening new opportunities for the market. For instance, in February 2022, in their seed funding, Qureight raised USD 1.50 million for their AI-based platform which reduces the timeline for the clinical trials process and further helps in reducing the cost of medicine development. Major bio-pharma giants are implementing advanced technological solutions for better patient management and clinical trial results.
These platforms further reduce clinical trial cycle time & cost, thereby increasing productivity & accuracy of the trial development. AI-based solutions incorporate natural language processing (NLP) algorithms which enhances the match rate between clinical trials and patient enrollment. For instance, AI-enabled clinical trial solutions used in matching patients have increased patient recruitment in lung cancer trial studies by 58.4%. Such advantages are further driving the market growth.
Based on therapeutic application, oncology held the largest market share 23.2% in 2021 owing to the rise in the prevalence of cancer all over the globe and rising initiatives to develop therapeutic solutions for oncology. However, the cardiovascular disease segment is expected to show the fastest growth rate during the forecast period owing to increasing cases of heart attack, stroke, and others.
Based on end users, pharmaceutical companies accounted for the highest revenue share of 66.0% owing to the growing focus on better development of bio-markers and diagnostics using AI-based technologies to identify the new medicine target and simplify the process of development of medicine and clinical trials by key players of pharmaceutical companies.
Based on the region North America held the largest market share of 43.8% in 2021. However, Asia Pacific is expected to show the fastest growth rate during the forecast period due to the increasing penetration of AI-based clinical technologies and supportive government initiatives for adopting AI.
AI-based Clinical Trial Solutions For Patient Matching Market Report Highlights
- The global AI-based clinical trial solutions for patient matching market size was valued at USD 230.6 million in 2021, owing to the increasing prevalence of chronic diseases and growing adoption of AI-based technologies in the clinical trial process
- In 2021, based on therapeutic applications, oncology accounted for the highest revenue share of 23.2%. The growing penetration rate of cancer throughout the world is leading to an increase in the number of clinical trials and thus, impacting the market positively
- In 2021, pharmaceutical companies accounted for the highest revenue share of 66.0% based on end-use. The growth is attributed to the rising usage of AI-based solutions for clinical trials
- North America dominated the AI-based clinical trial solution for patient matching with 43.8% of the total share in 2021, owing to the presence of key players, increasing prevalence of lifestyle disorders, growing elderly population, and growing advancement in the healthcare sector
CHAPTER 1 RESEARCH METHODOLOGY & SCOPE
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database
1.3.1.2 GVR’s internal database
1.3.2 Primary Research
1.4 Research Scope and Assumptions
1.5 List of Data Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
CHAPTER 3 GLOBAL AI-BASED CLINICAL TRIAL SOLUTIONS FOR PATIENT MATCHING MARKET VARIABLES, TRENDS, & SCOPE
3.1 Penetration and Growth Prospect Mapping
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Global AI-based Clinical Trial Solutions for Patient Matching Market Analysis Tools
3.3.1 Industry Analysis - Porter’s
3.3.1.1 Bargaining power of the suppliers
3.3.1.2 Bargaining power of the buyers
3.3.1.3 Threats of substitution
3.3.1.4 Threats from new entrants
3.3.1.5 Competitive rivalry
3.4. PESTEL Analysis
3.4.1 Political landscape
3.4.2 Economic and Social landscape
3.4.3 Technology landscape
3.4.4 Legal landscape
3.4.5 Technology landscape
3.5. Major Deals & Strategic Alliances Analysis
3.6 COVID-19 Impact on the market
CHAPTER 4 AI-BASED CLINICAL TRIAL SOLUTIONS FOR PATIENT MATCHING MARKET: THERAPEUTIC APPLICATION ESTIMATES & TREND ANALYSIS
4.1 Definitions & Scope
4.2 Global AI-based Clinical Trial Solutions for Patient Matching Market: Therapeutic Application Market Share Analysis, 2021 and 2030
4.3 Oncology
4.3.1 Oncology analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.4 Cardiovascular Diseases
4.4.1 Cardiovascular Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.5 Neurological Diseases or Conditions
4.5.1 Neurological Diseases or Conditions Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.6 Metabolic Diseases
4.6.1 Metabolic Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.7 Infectious Diseases
4.7.1 Infectious Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.8 Others
4.8.1 Others analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
CHAPTER 5 AI-BASED CLINICAL TRIAL SOLUTIONS FOR PATIENT MATCHING MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1 Definitions & Scope
5.2 Global AI-based Clinical Trial Solutions for Patient Matching Market: End-Use Market Share Analysis, 2020 and 2030
5.3 Pharmaceutical Companies
5.3.1 Pharmaceutical Companies Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
5.4 Academia
5.4.1 Academia analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
5.5 Others
5.5.1 Others analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
CHAPTER 6 AI-BASED CLINICAL TRIAL SOLUTIONS FOR PATIENT MATCHING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY THERAPEUTIC APPLICATION & END-USE
6.1 Global AI-based Clinical Trial Solutions for Patient Matching Market: Regional Movement Analysis
6.2 North America
6.2.1 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts ByTherapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts by Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.4 Spain
6.3.4.1 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.5 France
6.3.5.1 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.6 Italy
6.3.6.1 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.7 Russia
6.3.7.1 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4.2 China
6.4.2.1 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4.3 Japan
6.4.3.1 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4.5 South Korea
6.4.5.1 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4.6 Australia
6.4.6.1 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.6.4 UAE
6.6.4.1 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
CHAPTER 7 COMPANY PROFILES
7.1 Unlearn.AI, Inc.
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Antidote Technologies, Inc.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Deep6.ai
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Mendel.ai
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Aris Global
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Deep Lens AI
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 AmeriSourceBergen Corporation
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Koneksa
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Microsoft Corporation
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 GNS Healthcare
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database
1.3.1.2 GVR’s internal database
1.3.2 Primary Research
1.4 Research Scope and Assumptions
1.5 List of Data Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
CHAPTER 3 GLOBAL AI-BASED CLINICAL TRIAL SOLUTIONS FOR PATIENT MATCHING MARKET VARIABLES, TRENDS, & SCOPE
3.1 Penetration and Growth Prospect Mapping
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Global AI-based Clinical Trial Solutions for Patient Matching Market Analysis Tools
3.3.1 Industry Analysis - Porter’s
3.3.1.1 Bargaining power of the suppliers
3.3.1.2 Bargaining power of the buyers
3.3.1.3 Threats of substitution
3.3.1.4 Threats from new entrants
3.3.1.5 Competitive rivalry
3.4. PESTEL Analysis
3.4.1 Political landscape
3.4.2 Economic and Social landscape
3.4.3 Technology landscape
3.4.4 Legal landscape
3.4.5 Technology landscape
3.5. Major Deals & Strategic Alliances Analysis
3.6 COVID-19 Impact on the market
CHAPTER 4 AI-BASED CLINICAL TRIAL SOLUTIONS FOR PATIENT MATCHING MARKET: THERAPEUTIC APPLICATION ESTIMATES & TREND ANALYSIS
4.1 Definitions & Scope
4.2 Global AI-based Clinical Trial Solutions for Patient Matching Market: Therapeutic Application Market Share Analysis, 2021 and 2030
4.3 Oncology
4.3.1 Oncology analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.4 Cardiovascular Diseases
4.4.1 Cardiovascular Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.5 Neurological Diseases or Conditions
4.5.1 Neurological Diseases or Conditions Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.6 Metabolic Diseases
4.6.1 Metabolic Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.7 Infectious Diseases
4.7.1 Infectious Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.8 Others
4.8.1 Others analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
CHAPTER 5 AI-BASED CLINICAL TRIAL SOLUTIONS FOR PATIENT MATCHING MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1 Definitions & Scope
5.2 Global AI-based Clinical Trial Solutions for Patient Matching Market: End-Use Market Share Analysis, 2020 and 2030
5.3 Pharmaceutical Companies
5.3.1 Pharmaceutical Companies Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
5.4 Academia
5.4.1 Academia analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
5.5 Others
5.5.1 Others analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
CHAPTER 6 AI-BASED CLINICAL TRIAL SOLUTIONS FOR PATIENT MATCHING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY THERAPEUTIC APPLICATION & END-USE
6.1 Global AI-based Clinical Trial Solutions for Patient Matching Market: Regional Movement Analysis
6.2 North America
6.2.1 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts ByTherapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts by Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.4 Spain
6.3.4.1 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.5 France
6.3.5.1 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.6 Italy
6.3.6.1 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.3.7 Russia
6.3.7.1 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4.2 China
6.4.2.1 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4.3 Japan
6.4.3.1 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4.5 South Korea
6.4.5.1 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.4.6 Australia
6.4.6.1 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
6.6.4 UAE
6.6.4.1 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
CHAPTER 7 COMPANY PROFILES
7.1 Unlearn.AI, Inc.
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Antidote Technologies, Inc.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Deep6.ai
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Mendel.ai
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Aris Global
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Deep Lens AI
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 AmeriSourceBergen Corporation
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Koneksa
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Microsoft Corporation
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 GNS Healthcare
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives
LIST OF TABLES
TABLE 1 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 2 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 3 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 4 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 5 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 6 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 7 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 8 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 9 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 10 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 11 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 12 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 13 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 14 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 15 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 16 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 17 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 18 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 19 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 20 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 21 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 22 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 23 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 24 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 25 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 26 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 27 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 28 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 29 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 30 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 31 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 32 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 33 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 34 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 35 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 36 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 37 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 38 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 39 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 40 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 41 Middle East & Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 42 Middle East & Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 43 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 44 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 45 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 46 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 47 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 48 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 1 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 2 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 3 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 4 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 5 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 6 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 7 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 8 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 9 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 10 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 11 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 12 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 13 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 14 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 15 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 16 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 17 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 18 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 19 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 20 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 21 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 22 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 23 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 24 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 25 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 26 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 27 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 28 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 29 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 30 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 31 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 32 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 33 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 34 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 35 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 36 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 37 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 38 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 39 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 40 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 41 Middle East & Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 42 Middle East & Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 43 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 44 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 45 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 46 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
TABLE 47 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
TABLE 48 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
LIST OF FIGURES
FIG. 1 Market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 AI-based Clinical Trial Solutions for Patient Matching market snapshot, 2021 (USD Million)
FIG. 6 AI-based Clinical Trial Solutions for Patient Matching market trends & outlook
FIG. 7 Penetration & growth prospect mapping
FIG. 8 Market driver analysis (Current & future impact)
FIG. 9 Market restraint analysis (Current & future impact)
FIG. 10 AI-based Clinical Trial Solutions for Patient Matching market, therapeutic application outlook key takeaways (USD Million)
FIG. 11 AI-based Clinical Trial Solutions for Patient Matching market: therapeutic application movement analysis (USD Million), 2020 & 2030
FIG. 12 Oncology Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 13 Cardiovascular diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 14 Neurological Diseases or Conditions Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 15 Metabolic Diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 16 Infectious Diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 17 Other Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 18 AI-based Clinical Trial Solutions for Patient Matching market, end-use outlook key takeaways (USD Million)
FIG. 19 AI-based Clinical Trial Solutions for Patient Matching market: end-use movement analysis (USD Million), 2020 & 2030
FIG. 20 Pharmaceutical companies Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 21 Academia Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 22 Others Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 23 AI-based Clinical Trial Solutions for Patient Matching market, regional outlook key takeaways (USD Million)
FIG. 24 AI-based Clinical Trial Solutions for Patient Matching market: Regional movement analysis (USD Million), 2020 & 2030
FIG. 25 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 26 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 27 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 28 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 29 U.K AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 30 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 31 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 32 France-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 33 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 34 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 35 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 36 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 37 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 38 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 39 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 40 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 41 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 42 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 43 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 44 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 45 MEA AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 46 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 47 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 48 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 1 Market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 AI-based Clinical Trial Solutions for Patient Matching market snapshot, 2021 (USD Million)
FIG. 6 AI-based Clinical Trial Solutions for Patient Matching market trends & outlook
FIG. 7 Penetration & growth prospect mapping
FIG. 8 Market driver analysis (Current & future impact)
FIG. 9 Market restraint analysis (Current & future impact)
FIG. 10 AI-based Clinical Trial Solutions for Patient Matching market, therapeutic application outlook key takeaways (USD Million)
FIG. 11 AI-based Clinical Trial Solutions for Patient Matching market: therapeutic application movement analysis (USD Million), 2020 & 2030
FIG. 12 Oncology Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 13 Cardiovascular diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 14 Neurological Diseases or Conditions Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 15 Metabolic Diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 16 Infectious Diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 17 Other Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 18 AI-based Clinical Trial Solutions for Patient Matching market, end-use outlook key takeaways (USD Million)
FIG. 19 AI-based Clinical Trial Solutions for Patient Matching market: end-use movement analysis (USD Million), 2020 & 2030
FIG. 20 Pharmaceutical companies Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 21 Academia Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 22 Others Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 23 AI-based Clinical Trial Solutions for Patient Matching market, regional outlook key takeaways (USD Million)
FIG. 24 AI-based Clinical Trial Solutions for Patient Matching market: Regional movement analysis (USD Million), 2020 & 2030
FIG. 25 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 26 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 27 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 28 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 29 U.K AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 30 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 31 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 32 France-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 33 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 34 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 35 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 36 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 37 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 38 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 39 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 40 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 41 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 42 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 43 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 44 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 45 MEA AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 46 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 47 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
FIG. 48 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
